DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,088 filers reported holding DANAHER CORPORATION in Q2 2016. The put-call ratio across all filers is 0.21 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,627,498,373 | +7.7% | 14,621,738 | +4.2% | 0.92% | +13.3% |
| Q2 2023 | $3,366,676,648 | +16.2% | 14,029,348 | +22.0% | 0.81% | +9.0% |
| Q1 2023 | $2,897,293,252 | +15.8% | 11,496,682 | +22.0% | 0.74% | +10.9% |
| Q4 2022 | $2,502,385,567 | +3.8% | 9,427,276 | +1.1% | 0.67% | -4.4% |
| Q3 2022 | $2,409,658,000 | +3.9% | 9,327,279 | +2.0% | 0.70% | +11.4% |
| Q2 2022 | $2,318,340,000 | -8.5% | 9,144,947 | +5.9% | 0.63% | +9.4% |
| Q1 2022 | $2,532,715,000 | -2.6% | 8,632,617 | +9.2% | 0.58% | +4.9% |
| Q4 2021 | $2,601,625,000 | +8.3% | 7,907,683 | +0.3% | 0.55% | +0.2% |
| Q3 2021 | $2,401,381,000 | +13.4% | 7,886,794 | -0.0% | 0.55% | +13.4% |
| Q2 2021 | $2,117,477,000 | +27.5% | 7,889,048 | +6.9% | 0.48% | +15.2% |
| Q1 2021 | $1,660,906,000 | +21.7% | 7,380,506 | +20.1% | 0.42% | +12.6% |
| Q4 2020 | $1,365,022,000 | -0.1% | 6,145,758 | -3.2% | 0.37% | -11.6% |
| Q3 2020 | $1,366,229,000 | +16.8% | 6,346,912 | -4.1% | 0.42% | +10.2% |
| Q2 2020 | $1,169,598,000 | +24.2% | 6,616,796 | -2.7% | 0.38% | -0.5% |
| Q1 2020 | $941,564,000 | -0.8% | 6,802,713 | +10.0% | 0.38% | +19.6% |
| Q4 2019 | $948,992,000 | +6.3% | 6,183,163 | +0.0% | 0.32% | -5.6% |
| Q3 2019 | $892,739,000 | +6.8% | 6,181,119 | +5.6% | 0.34% | +2.1% |
| Q2 2019 | $836,276,000 | +7.8% | 5,851,358 | -0.4% | 0.33% | +0.3% |
| Q1 2019 | $775,479,000 | +54.2% | 5,873,950 | +20.4% | 0.33% | +32.7% |
| Q4 2018 | $502,890,000 | +62.8% | 4,876,744 | +71.6% | 0.25% | +78.0% |
| Q3 2018 | $308,842,000 | +34.0% | 2,842,280 | +21.7% | 0.14% | -45.8% |
| Q2 2018 | $230,449,000 | +1.1% | 2,335,318 | +0.3% | 0.26% | -1.1% |
| Q1 2018 | $227,930,000 | +5.8% | 2,327,958 | +0.3% | 0.26% | +8.2% |
| Q4 2017 | $215,478,000 | +8.6% | 2,321,467 | +0.3% | 0.24% | +2.1% |
| Q3 2017 | $198,498,000 | +8.9% | 2,314,041 | +7.1% | 0.24% | -2.5% |
| Q2 2017 | $182,341,000 | -1.1% | 2,160,695 | +0.2% | 0.24% | -2.8% |
| Q1 2017 | $184,412,000 | +10.1% | 2,156,114 | +0.2% | 0.25% | +3.7% |
| Q4 2016 | $167,421,000 | -0.5% | 2,150,831 | +0.2% | 0.24% | -0.8% |
| Q3 2016 | $168,328,000 | -22.2% | 2,147,319 | +0.3% | 0.24% | -23.0% |
| Q2 2016 | $216,267,000 | +6.6% | 2,141,260 | +0.1% | 0.32% | +1.9% |
| Q1 2016 | $202,961,000 | +2.1% | 2,139,583 | +0.0% | 0.31% | +1.3% |
| Q4 2015 | $198,722,000 | +17.1% | 2,139,552 | +7.4% | 0.31% | -0.3% |
| Q3 2015 | $169,721,000 | -0.4% | 1,991,794 | +0.1% | 0.31% | +6.6% |
| Q2 2015 | $170,370,000 | +12.2% | 1,990,534 | +11.3% | 0.29% | +4.7% |
| Q1 2015 | $151,861,000 | -0.9% | 1,788,700 | 0.0% | 0.28% | -12.4% |
| Q4 2014 | $153,309,000 | +42.7% | 1,788,700 | +26.5% | 0.32% | +20.2% |
| Q3 2014 | $107,428,000 | -3.5% | 1,413,900 | 0.0% | 0.26% | -9.0% |
| Q2 2014 | $111,316,000 | +5.0% | 1,413,900 | 0.0% | 0.29% | +1.1% |
| Q1 2014 | $106,043,000 | -2.8% | 1,413,900 | 0.0% | 0.28% | -15.9% |
| Q4 2013 | $109,153,000 | +11.4% | 1,413,900 | 0.0% | 0.34% | -19.1% |
| Q3 2013 | $98,012,000 | – | 1,413,900 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |